These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32068430)

  • 21. Pharmacokinetic properties of γ-hydroxybutyrate (GHB) in whole blood, serum, and urine.
    Brailsford AD; Cowan DA; Kicman AT
    J Anal Toxicol; 2012 Mar; 36(2):88-95. PubMed ID: 22337777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatalities associated with the use of gamma-hydroxybutyrate and its analogues in Australasia.
    Caldicott DG; Chow FY; Burns BJ; Felgate PD; Byard RW
    Med J Aust; 2004 Sep; 181(6):310-3. PubMed ID: 15377240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circumstances of death of opioid users being treated with naltrexone.
    Darke S; Farrell M; Duflou J; Larance B; Lappin J
    Addiction; 2019 Nov; 114(11):2000-2007. PubMed ID: 31278812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of gamma hydroxybutyrate in emergency department: Nice to have or a valuable diagnostic tool?
    Drogies T; Willenberg A; Ramshorn-Zimmer A; Weidhase L; Petros S; Hädrich C; Thiery J; Gries A; Bernhard M
    Hum Exp Toxicol; 2016 Jul; 35(7):785-92. PubMed ID: 26395197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship Between Postmortem Urine and Blood Concentrations of GHB Furnishes Useful Information to Help Interpret Drug Intoxication Deaths.
    Jones AW; Holmgren A; Kugelberg FC; Busardò FP
    J Anal Toxicol; 2018 Nov; 42(9):587-591. PubMed ID: 29905804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
    Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
    Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Area-level socioeconomic status in relation to outcomes in gamma-hydroxybutyrate intoxication.
    Anderson IB; Kim-Katz SY; Dyer JE; Earnest GE; Lamb JP; Blanc PD
    Clin Toxicol (Phila); 2009 Jan; 47(1):48-57. PubMed ID: 18787999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in gamma-hydroxybutyrate-related harms based on ambulance attendances from 2012 to 2018 in Victoria, Australia.
    Arunogiri S; Moayeri F; Crossin R; Killian JJ; Smith K; Scott D; Lubman DI
    Addiction; 2020 Mar; 115(3):473-479. PubMed ID: 31618793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics and dose-effect relationship of clinical gamma-hydroxybutyrate intoxication: A case series.
    Abid M; Kietzerow J; Iwersen-Bergmann S; Schnitgerhans T; Andresen-Streichert H
    J Forensic Sci; 2022 Jan; 67(1):416-427. PubMed ID: 34523720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An observed rise in γ-hydroxybutyrate-associated deaths in London: Evidence to suggest a possible link with concomitant rise in chemsex.
    Hockenhull J; Murphy KG; Paterson S
    Forensic Sci Int; 2017 Jan; 270():93-97. PubMed ID: 27936427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rates, characteristics and manner of cannabis-related deaths in Australia 2000-2018.
    Zahra E; Darke S; Degenhardt L; Campbell G
    Drug Alcohol Depend; 2020 Jul; 212():108028. PubMed ID: 32370933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postmortem concentrations of gamma-hydroxybutyrate (GHB) in peripheral blood and brain tissue - Differentiating between postmortem formation and antemortem intake.
    Thomsen R; Rasmussen BS; Johansen SS; Linnet K
    Forensic Sci Int; 2017 Mar; 272():154-158. PubMed ID: 28111035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology.
    Kaye S; Darke S; Duflou J; McKetin R
    Addiction; 2008 Aug; 103(8):1353-60. PubMed ID: 18855825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twenty-three deaths with gamma-hydroxybutyrate overdose in western Sweden between 2000 and 2007.
    Knudsen K; Jonsson U; Abrahamsson J
    Acta Anaesthesiol Scand; 2010 Sep; 54(8):987-92. PubMed ID: 20701597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of fatal 'novel' benzodiazepine toxicity in Australia.
    Darke S; Peacock A; Duflou J; Farrell M; Lappin J
    Forensic Sci Int; 2022 Feb; 331():111140. PubMed ID: 34894611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suspected GHB overdoses in the emergency department.
    Couper FJ; Thatcher JE; Logan BK
    J Anal Toxicol; 2004 Sep; 28(6):481-4. PubMed ID: 15516299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GHB concentration in a related post-mortem case.
    Mortali C; Berretta P
    Clin Ter; 2020; 171(3):e235-e236. PubMed ID: 32323711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood, brain, and hair GHB concentrations following fatal ingestion.
    Kalasinsky KS; Dixon MM; Schmunk GA; Kish SJ
    J Forensic Sci; 2001 May; 46(3):728-30. PubMed ID: 11373018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of fatal tapentadol-related toxicity in Australia.
    Darke S; Duflou J; Peacock A; Farrell M; Lappin J
    Drug Alcohol Rev; 2022 Jul; 41(5):1071-1077. PubMed ID: 35301769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use.
    Liechti ME; Kunz I; Greminger P; Speich R; Kupferschmidt H
    Drug Alcohol Depend; 2006 Feb; 81(3):323-6. PubMed ID: 16143455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.